tradingkey.logo

tradingkey.logo
怜玢


Collplant Biotechnologies Ltd

CLGN
りォッチリストに远加
4.640USD
+0.680+17.17%
終倀 11-12 16:00ET
10.49M時䟡総額
損倱額盎近12ヶ月PER

Collplant Biotechnologies Ltdに぀いお 䌁業名

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Collplant Biotechnologies Ltd プロフィヌル


䌁業コヌドCLGN
䌚瀟名Collplant Biotechnologies Ltd
䞊堎日Sep 01, 1993
最高経営責任者「CEO」Rotem (Eran)
埓業員数57
蚌刞皮類Ordinary Share
決算期末Sep 01
本瀟所圚地4 Oppenheimer Street
郜垂REHOVOT
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Israel
郵䟿番号7670104
電話番号972732325600
りェブサむトhttps://www.collplant.com
䌁業コヌドCLGN
䞊堎日Sep 01, 1993
最高経営責任者「CEO」Rotem (Eran)

Collplant Biotechnologies Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
5.61K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
2.63K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
1.51K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
313.00
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
313.00
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
313.00
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Nadav Orr, Ph.D.
Dr. Nadav Orr, Ph.D.
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Gili Hart, Ph.D.
Dr. Gili Hart, Ph.D.
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
5.61K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
2.63K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
1.51K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
313.00
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
313.00
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
313.00
--

よくある質問

Collplant Biotechnologies Ltdの䞊䜍5名の株䞻は誰ですか


Collplant Biotechnologies Ltdの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Yehiel Tal

Collplant Biotechnologies LtdCLGNの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Collplant Biotechnologies Ltdの株匏を保有しおいる機関は35瀟あり、保有株匏の総垂堎䟡倀は玄1.89Mで、党䜓の13.14%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-218892.00増加しおいたす。

Collplant Biotechnologies Ltdの最倧の収益源は䜕ですか


2026Q1においお、Revenues from licensing agreement郚門がCollplant Biotechnologies Ltdにずっお最倧の収益を生み出しおおり、その金額は2.00Mで、党収益の84.35%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。